Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. (TSHA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
tsha · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$13.00
Consensus
$12.00
+121.0% upside
Low
$11.00
Median: $12 · Last Close: $5.43
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$12.00
121.0% upside
High Target
$13
139.4%
Low Target
$11
102.6%
Current Price
$5.43
as of today
Based on analyst price targets, the TSHA stock price prediction for the next 12 months ranges from $11 to $13. The consensus TSHA price forecast of $12.00 implies 121.0% upside from the current price of $5.43.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.28 | ↓ 2.80% |
1-day model range: $5.24–$5.31. Peak: $5.31 (-2.80%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TSHA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-06 | Canaccord Genuity | Maintains | Buy→Buy |
| 2026-03-19 | Chardan Capital | Maintains | Buy→Buy |
| 2026-03-19 | Needham | Maintains | Buy→Buy |
| 2026-03-03 | Needham | Maintains | Buy→Buy |
| 2026-01-06 | Chardan Capital | Maintains | Buy→Buy |
| 2026-01-05 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-11-05 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-05 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-17 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-17 | Needham | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Taysha Gene Therapies, Inc. (TSHA) stock. Of the recent 120 rating actions, 0 were upgrades and 4 were downgrades. 16 analysts currently cover TSHA.
Analyst Recommendation Trends
TSHA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 98.7% YoY
Revenue Next Year
$39M
↑ 1844.9% YoY
EPS This Year
$-0.48
EPS Next Year
$-0.32
↓ 32.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast TSHA EPS of $-0.48 for the current fiscal year, based on estimates from 7 analysts. The TSHA revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The TSHA stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus TSHA price target is $12.00 (+121.0% upside), with an analyst consensus of Buy.
The TSHA short-term stock prediction for tomorrow is $5.28 (-2.80%).
Taysha Gene Therapies, Inc. trades on NASDAQ under the ticker TSHA. The TSHA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
TSHA forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month TSHA price target is $12.00, with a high forecast of $13.00 and a low of $11.00. The median price target is shown in the chart above when available. This implies +121.0% potential upside from the current price of $5.43.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.